Oncologists generally refer to specialized palliative care late

Oncologists generally refer to specialized palliative care late
Definitional issues and non-acceptance of patients receiving chemotherapy are the barriers to earlier referral to specialized palliative care by oncologists, according to a study published online Oct. 29 in the Journal of Clinical Oncology.

(HealthDay)—Definitional issues and non-acceptance of patients receiving chemotherapy are the barriers to earlier referral to specialized palliative care (SPC) by oncologists, according to a study published online Oct. 29 in the Journal of Clinical Oncology.

Kirsten Wentlandt, M.D., Ph.D., from the University of Toronto, and colleagues anonymously surveyed physician members of the Canadian Association of Medical Oncologists, Canadian Association of , and Canadian Society of Surgical regarding SPC referral practices.

The researchers found that, of the 603 participating physicians among 839 surveyed, 94 percent reported that SPC was available to them, but only 37 percent said that these services accepted patients on chemotherapy. Terminally ill patients were usually/always referred by 84 percent of reporting physicians, but generally for uncontrolled symptoms or discharge planning late in the disease course. If SPC was renamed supportive care, one-third of physicians said they would refer earlier. Comprehensiveness of available SPC services, satisfaction with SPC availability, SPC acceptance of patients receiving , and oncologist ease with referring patients to a palliative care service before they were close to death were the factors significantly predictive of higher referral frequency.

"Oncologists referred patients frequently to SPC, but generally late in the disease course for patients with uncontrolled symptoms," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Few physicians refer patients to cancer clinical trials

date Feb 12, 2011

A small proportion of adult cancer patients participate in clinical trials in part due to a low level of physician referrals, according to an online study published Feb. 11 in The Journal of the National Cancer Institute.

Recommended for you

Vortex device makes for better cancer treatments

date May 22, 2015

A South Australian invention, responsible for unboiling an egg, has been used to produce a four-fold increase in efficacy of carboplatin, a commonly used drug for ovarian, lung and other cancer. ...

Using healthy skin to identify cancer's origins

date May 21, 2015

Normal skin contains an unexpectedly high number of cancer-associated mutations, according to a study published in Science. The findings illuminate the first steps cells take towards becoming a cancer and de ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.